MAPT and tauopathy: This interpretation is also supported by preclinical work, showing that pathological tau species from 4-repeat (i.e., CBD/PSP) and mixed 3/4-repeat tauopathies (i.e., AD) consistently trigger trans-cellular tau spread across connected brain regions while recapitulating disease-specific neuropathological hallmark features (e.g., neuronal tau in AD vs. neuronal and glial tau in CBD/PSP)15, 17, 42.